Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers

NCT07316400

completed

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP

NCT04221191

completednot_applicable

New Setting of Neurally Adjusted Ventilatory Assist During Mask Noninvasive Ventilation

NCT03041402

Clinical Trials (3)

Showing 3 of 3 trials

NCT07316400Not Applicable

PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers

Completed

NCT04221191

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP

Completed

NCT03041402Not Applicable

New Setting of Neurally Adjusted Ventilatory Assist During Mask Noninvasive Ventilation

Completed

All 3 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 3